Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis

NCT05809414 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Fatigue

Interventions

DEVICE: Transcranial Magnetic Stimulation
DRUG: Amantadine Hydrochloride 100 mg (milligrams) Oral Capsule

Sponsor

Hospital San Carlos, Madrid